Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, Respiratory Inflammation and Autoimmunity Innovative Medicines, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.

Published: July 2013

A series of zwitterionic spirocyclic compounds were synthesised. In vitro data revealed that these compounds were potent CCR1 antagonists. In particular, 2, 4, 11 and 20 inhibited CCR1 mediated chemotaxis of THP-1 cells in a functional assay.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2013.05.087DOI Listing

Publication Analysis

Top Keywords

zwitterionic spirocyclic
8
spirocyclic compounds
8
compounds potent
8
potent ccr1
8
ccr1 antagonists
8
design synthesis
4
synthesis structure-activity
4
structure-activity relationships
4
relationships zwitterionic
4
antagonists series
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!